Published on in Vol 7, No 4 (2021): Oct-Dec
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/25776, first published
.
![Measuring the Time to Deterioration for Health-Related Quality of Life in Patients With Metastatic Breast Cancer Using a Web-Based Monitoring Application: Longitudinal Cohort Study Measuring the Time to Deterioration for Health-Related Quality of Life in Patients With Metastatic Breast Cancer Using a Web-Based Monitoring Application: Longitudinal Cohort Study](https://asset.jmir.pub/assets/77b1b1c4db657029d4f7805daf3ce5bc.png 480w,https://asset.jmir.pub/assets/77b1b1c4db657029d4f7805daf3ce5bc.png 960w,https://asset.jmir.pub/assets/77b1b1c4db657029d4f7805daf3ce5bc.png 1920w,https://asset.jmir.pub/assets/77b1b1c4db657029d4f7805daf3ce5bc.png 2500w)
Journals
- Zhuang J, Liu Y, Xu X, Cai Y, Liu M, Chen Z, Yang S, Lin J, Hu Z, Kang M, Lin M, He F. Association between physical activity and health-related quality of life: time to deterioration model analysis in lung adenocarcinoma. Journal of Cancer Survivorship 2023;17(6):1769 View
- Deutsch T, Pfob A, Brusniak K, Riedel F, Bauer A, Dijkstra T, Engler T, Brucker S, Hartkopf A, Schneeweiss A, Sidey-Gibbons C, Wallwiener M. Machine learning and patient-reported outcomes for longitudinal monitoring of disease progression in metastatic breast cancer: a multicenter, retrospective analysis. European Journal of Cancer 2023;188:111 View
- Tsai C, Yang J, Shaverdian N, Patel J, Shepherd A, Eng J, Guttmann D, Yeh R, Gelblum D, Namakydoust A, Preeshagul I, Modi S, Seidman A, Traina T, Drullinsky P, Flynn J, Zhang Z, Rimner A, Gillespie E, Gomez D, Lee N, Berger M, Robson M, Reis-Filho J, Riaz N, Rudin C, Powell S, Bromberg J, Chen L, Dang C, Das J, Eng J, Girshman J, Gucalp A, Hajj C, Higginson D, Iqbal A, Khan A, LaPlant Q, Mann J, Ng K, Reyngold M, Sanford R, Seidman A, Shah R, Shin J, Sugarman S, Traina T, Tsai C, Wu A, Xu A, Zhi W. Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study. The Lancet 2024;403(10422):171 View
- Chen Z, Zhuang J, Liu M, Xu X, Liu Y, Yang S, Xie J, Lin N, Lai F, He F. Longitudinal analysis of quality of life in primary lung cancer patients with chlamydia pneumoniae infection: a time-to-deterioration model. BMC Pulmonary Medicine 2024;24(1) View
- Luu T, Dinh D, Tran T, Tran T, Tran H, Pham K, Nguyen H, Jayadevappa R. Health-state utility of patients with HER2-positive breast cancer in Vietnam: A multicenter cross-sectional study. PLOS ONE 2024;19(5):e0303011 View